Connect with us
Bayer posted a profit of €2.99 billion in the first half of 2022, compared with a loss of €246 million in the first half of last...
The figures in the pharmaceuticals area are cemented especially by the performance of Bayer's cardiovascular treatments and for the prevention of age-related ophthalmological diseases. Another highlight...
According to the latest published accounts, Bayer's sales rose by 5% between January and September 2021 compared with the same period in 2020, to $37 billion...
The most sensational news came, on December 7th, from the Tübingen headquarters of Curevac, when its CEO Franz-Werner Haas announced the upcoming application for approval of...
Effectively ending their self-imposed halt this year, drugmakers will start the new year with drug price increases.